Preclinical Evaluation of an Imidazole-Linked Heterocycle for Alzheimer’s Disease

Humanity is facing a vast prevalence of neurodegenerative diseases, with Alzheimer’s disease (AD) being the most dominant, without efficacious drugs, and with only a few therapeutic targets identified. In this scenario, we aim to find molecular entities that modulate imidazoline I(2) receptors (I(2)...

Descripción completa

Detalles Bibliográficos
Autores principales: Bagán, Andrea, Rodriguez-Arévalo, Sergio, Taboada-Jara, Teresa, Griñán-Ferré, Christian, Pallàs, Mercè, Brocos-Mosquera, Iria, Callado, Luis F., Morales-García, José A., Pérez, Belén, Diaz, Caridad, Fernández-Godino, Rosario, Genilloud, Olga, Beljkas, Milan, Oljacic, Slavica, Nikolic, Katarina, Escolano, Carmen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10610545/
https://www.ncbi.nlm.nih.gov/pubmed/37896141
http://dx.doi.org/10.3390/pharmaceutics15102381

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10610545/
https://www.ncbi.nlm.nih.gov/pubmed/37896141
http://dx.doi.org/10.3390/pharmaceutics15102381

Ejemplares similares